Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Biologics : Targets & Therapy
|
March 6, 2026
First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison
Yi Zhu, Xiao Qi, Senmiao Ni, et al.
Cancers
|
August 26, 2022
The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer
Rui Geng, Tian Chen, Zihang Zhong, et al.
Journal of Applied Statistics
|
February 28, 2024
The heterogeneity effect of surveillance intervals on progression free survival
Zihang Zhong, Min Yang, Senmiao Ni, et al.
Statistical Methods in Medical Research
|
March 29, 2024
Sample size estimation for stratified cluster randomization trial with survival endpoint
Senmiao Ni, Zihang Zhong, Yang Zhao, et al.
Molecular Therapy. Nucleic Acids
|
March 1, 2022
Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC
Jinhui Liu, Rui Geng, Senmiao Ni, et al.
Biometrical Journal. Biometrische Zeitschrift
|
April 6, 2024
Beta spending function based on conditional power in group sequential design
Senmiao Ni, Zihang Zhong, Zhiwei Jiang, et al.
Journal of Biopharmaceutical Statistics
|
July 6, 2022
Risk difference, relative risk, and odds ratio for non-inferiority clinical trials with risk rate endpoint
Senmiao Ni, Quanji Yu, Zihang Zhong, et al.
Computational and Structural Biotechnology Journal
|
October 17, 2022
Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer
Jinhui Liu, Can Chen, Rui Geng, et al.
BMC Medical Research Methodology
|
April 30, 2026
Choose-NI-metric: a shiny application for converting and comparing non-inferiority metrics in binary endpoint trials
Wen Liu, Senmiao Ni, Ruyu Huang, et al.
Oxidative Medicine and Cellular Longevity
|
August 15, 2022
N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
Jinhui Liu, Rui Geng, Zihang Zhong, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Biologics : Targets & Therapy
|
March 6, 2026
First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison
Yi Zhu, Xiao Qi, Senmiao Ni, et al.
Cancers
|
August 26, 2022
The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer
Rui Geng, Tian Chen, Zihang Zhong, et al.
Journal of Applied Statistics
|
February 28, 2024
The heterogeneity effect of surveillance intervals on progression free survival
Zihang Zhong, Min Yang, Senmiao Ni, et al.
Statistical Methods in Medical Research
|
March 29, 2024
Sample size estimation for stratified cluster randomization trial with survival endpoint
Senmiao Ni, Zihang Zhong, Yang Zhao, et al.
Molecular Therapy. Nucleic Acids
|
March 1, 2022
Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC
Jinhui Liu, Rui Geng, Senmiao Ni, et al.
Biometrical Journal. Biometrische Zeitschrift
|
April 6, 2024
Beta spending function based on conditional power in group sequential design
Senmiao Ni, Zihang Zhong, Zhiwei Jiang, et al.
Journal of Biopharmaceutical Statistics
|
July 6, 2022
Risk difference, relative risk, and odds ratio for non-inferiority clinical trials with risk rate endpoint
Senmiao Ni, Quanji Yu, Zihang Zhong, et al.
Computational and Structural Biotechnology Journal
|
October 17, 2022
Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer
Jinhui Liu, Can Chen, Rui Geng, et al.
BMC Medical Research Methodology
|
April 30, 2026
Choose-NI-metric: a shiny application for converting and comparing non-inferiority metrics in binary endpoint trials
Wen Liu, Senmiao Ni, Ruyu Huang, et al.
Oxidative Medicine and Cellular Longevity
|
August 15, 2022
N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
Jinhui Liu, Rui Geng, Zihang Zhong, et al.
Page
of 3